Showing results (1111-1120 of 1,839) with videos related to

Sort By:
Pageof 184
Inorganic Chemistry|December 1, 2017
Cu(II) Binding to the Peptide Ala-His-His, a Chimera of the Canonical Cu(II)-Binding Motifs Xxx-His and Xxx-Zzz-HisPaulina Gonzalez, Bertrand Vileno, Karolina Bossak, et al.
Chemmedchem|May 12, 2007
Modeling promiscuity based on in vitro safety pharmacology profiling dataKamal Azzaoui, Jacques Hamon, Bernard Faller, et al.
Chemical Communications (Cambridge, England)|October 26, 2018
Cu transfer from amyloid-β<sub>4-16</sub> to metallothionein-3: the role of the neurotransmitter glutamate and metallothionein-3 Zn(ii)-load statesAlice Santoro, Nina Ewa Wezynfeld, Ewelina Stefaniak, et al.
Infection and Immunity|October 24, 1998
Antrum- and corpus mucosa-infiltrating CD4(+) lymphocytes in Helicobacter pylori gastritis display a Th1 phenotypeF Sommer, G Faller, P Konturek, et al.
Applied Optics|June 13, 2014
Investigation of the Young's modulus and thermal expansion of amorphous titania-doped tantala filmsMatthew R Abernathy, James Hough, Iain W Martin, et al.
Contact Dermatitis|April 8, 2015
Individual prevention courses for occupational skin diseases: changes in and relationships between proximal and distal outcomesMichael Schuler, Katja Spanier, Matthias Lukasczik, et al.
International Journal of Molecular Sciences|April 28, 2023
Prognostic and Predictive Biomarkers in the Era of Immunotherapy for Lung CancerLucile Pabst, Sébastien Lopes, Basil Bertrand, et al.
Micromachines|March 6, 2025
A New Means to Generate Liposomes by Rehydrating Engineered Lipid NanoconstructsYuqi Huang, Ziqian Xu, Umit Celik, et al.
Biochemistry|April 10, 2002
Structure-activity relationship of hydroxamate-based inhibitors on the secretases that cleave the amyloid precursor protein, angiotensin converting enzyme, CD23, and pro-tumor necrosis factor-alphaEdward T Parkin, Alison Trew, Gary Christie, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 25, 2018
Systematic Literature Review of Treatment Options and Clinical Outcomes for Patients With Higher-Risk Myelodysplastic Syndromes and Chronic Myelomonocytic LeukemiaJill A Bell, Aaron Galaznik, Rachel Huelin, et al.
Pageof 184